(Q39936393)

English

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines

scientific article published on 24 September 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Takashi Yamatodani

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Elisabeth Kjellén

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Anders Johnsson

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hiroyuki Mineta

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Johan Wennerberg

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

395-402

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Stat proteins and oncogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-008-0475-2

21 January 2018

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00432-008-0475-2

21 January 2018

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The STAT3 oncogene as a predictive marker of drug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signal transducers and activators of transcription: insights into the molecular basis of oral cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathwa

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor: mechanisms of activation and signalling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signaling through the epidermal growth factor receptor during the development of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STAT signaling in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27(KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why the epidermal growth factor receptor? The rationale for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric DNA analysis of human cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STATs in oncogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18813952

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-008-0475-2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39936393&oldid=2203266354"